Firms that sell price-controlled patent drugs spent $922.9 million on research in Canada in 2021, reported the Patented Medicines Price Review Board. That’s the biggest percentage increase since 2002, though it left research spending well below its $1.325-billion peak in 2007. (The Logic)
In-depth, agenda-setting reporting
Great journalism delivered straight to your inbox.
The Big Read
The Real story: How one of Canada’s pioneering VC firms hit the wall
Montreal’s RailVision Analytics raises US$4M in seed funding
Government launches BDC legislative review
Suncor to retain downstream assets in defiance of activist investor push
Best business newsletter in Canada
Get up to speed in minutes with insights and analysis on the most important stories of the day, every weekday.
See the bigger picture with reporters and industry experts in subscriber-exclusive events.
Membership in The Logic Council
Membership provides access to our popular Slack channel, participation in subscriber surveys and invitations to exclusive events with our journalists and special guests.